135 related articles for article (PubMed ID: 38220151)
1. [Posterior reversible encephalopathy syndrome during nilotinib treatment for chronic myeloid leukemia].
Kudo D; Suzuki H; Abe N; Hirai R; Tanimura A; Takeshita M; Miwa A
Rinsho Ketsueki; 2023; 64(12):1514-1518. PubMed ID: 38220151
[TBL] [Abstract][Full Text] [Related]
2. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M
Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537
[TBL] [Abstract][Full Text] [Related]
3. [PRES (Posterior Reversible Encephalopathy Syndrome): potential complication of hypertensive crisis. Case report and literature review].
Vergura M; Prencipe M; Del Giudice AM; Grifa R; Miscio F; Pennelli AM; Popolizio T; Simeone A; Ferrara M; Leone M; Aucella F
G Ital Nefrol; 2017 Apr; 34(2):100-109. PubMed ID: 28682567
[TBL] [Abstract][Full Text] [Related]
4. Finding the right BCR-ABL1 tyrosine kinase inhibitor: a case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib.
Elnair R; Galal A
BMC Cancer; 2018 Nov; 18(1):1097. PubMed ID: 30419862
[TBL] [Abstract][Full Text] [Related]
5. Reversible posterior encephalopathy syndrome in a 10-year-old child.
Carvalho EG; Peluso HGC; Batista LL; Moreira CS; Protti JSM; Soares MCB; Autran AFS; Almeida ARS; Rodrigues DC; Bernardes LVGR; Paula LP
J Bras Nefrol; 2019; 41(3):436-439. PubMed ID: 30281063
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib-induced Posterior Reversible Encephalopathy Syndrome in a Child With FLT3-ITD-positive Acute Myeloid Leukemia.
Tavil B; Isgandarova F; Bayhan T; Unal S; Kuskonmaz B; Gumruk F; Cetin M
J Pediatr Hematol Oncol; 2016 Apr; 38(3):240-2. PubMed ID: 26907662
[TBL] [Abstract][Full Text] [Related]
7. Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review.
Smets GJ; Loyson T; Van Paesschen W; Demaerel P; Nackaerts K
Acta Clin Belg; 2018 Oct; 73(5):382-388. PubMed ID: 29173113
[TBL] [Abstract][Full Text] [Related]
8. [A case of cerebellar variant of posterior reversible encephalopathy syndrome in puerperium].
Uchiyama T; Okamoto H; Koguchi M; Ogata A; Suzuyama K; Matsushima T
No Shinkei Geka; 2013 Aug; 41(8):697-702. PubMed ID: 23907477
[TBL] [Abstract][Full Text] [Related]
9. Posterior reversible encephalopathy syndrome triggered by FLOT (5-fluorouracil, oxaliplatin, docetaxel, and calcium levofolinate) chemotherapy and thrombocytopenia (docetaxel and cisplatin) chemotherapy.
Xie L
J Oncol Pharm Pract; 2023 Sep; 29(6):1503-1509. PubMed ID: 37218162
[TBL] [Abstract][Full Text] [Related]
10. [Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case report].
Zhang XH; Deng XR; Li F; Zhu Y; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1102-1107. PubMed ID: 30562790
[TBL] [Abstract][Full Text] [Related]
11. Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome.
Yang Q; Chang CC; Liu M; Yu YQ
BMC Med Imaging; 2019 Apr; 19(1):35. PubMed ID: 31039748
[TBL] [Abstract][Full Text] [Related]
12. Posterior Reversible Leucoencephalopathy Syndrome: Case Series, Comments, and Diagnostic Dilemma.
Chaudhuri J; Basu S; Roy MK; Chakravarty A
Curr Neurol Neurosci Rep; 2023 Aug; 23(8):433-449. PubMed ID: 37378723
[TBL] [Abstract][Full Text] [Related]
13. Posterior reversible encephalopathy syndrome with spinal cord involvement but without hemisphere lesions: A case report.
Liu L; Dai D; Cao F; Zhang L; Wang X
Medicine (Baltimore); 2019 Jan; 98(2):e13649. PubMed ID: 30633153
[TBL] [Abstract][Full Text] [Related]
14. Posterior reversible encephalopathy syndrome (PRES) associated with SARS-CoV-2 infection in a patient under maintenance haemodialysis: a case report.
Shimamoto Y; Sasaki H; Kasuno K; Watanabe Y; Sakashita S; Nishikawa S; Nishimori K; Morita S; Nishikawa Y; Kobayashi M; Fukushima S; Enomoto S; Takahashi N; Hamano T; Sakamaki I; Iwasaki H; Iwano M
BMC Nephrol; 2023 Sep; 24(1):286. PubMed ID: 37773103
[TBL] [Abstract][Full Text] [Related]
15. [Case of posterior reversible encephalopathy syndrome due to azathioprine].
Ogawa R; Oikawa T; Shijo T; Kanno S; Shibuya S; Mochizuki H
Rinsho Shinkeigaku; 2015; 55(12):936-9. PubMed ID: 26511023
[TBL] [Abstract][Full Text] [Related]
16. Isolated brainstem involvement in posterior reversible encephalopathy syndrome: a case report and review of the literature.
Liu C; Cao J; Su Z; Xu S
Int J Neurosci; 2019 Aug; 129(8):808-813. PubMed ID: 30590967
[TBL] [Abstract][Full Text] [Related]
17. [Case of posterior reversible encephalopathy syndrome caused by Fisher syndrome].
Yokoi K; Ando T; Kawakami O
Rinsho Shinkeigaku; 2018 Jan; 58(1):45-48. PubMed ID: 29269696
[TBL] [Abstract][Full Text] [Related]
18. Posterior Reversible Encephalopathy Syndrome Associated with Sorafenib and Successful Retreatment.
Laruelle M; Filleul B; Duprez T; Machiels JP
Urol Int; 2018; 100(3):357-360. PubMed ID: 26845702
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Protein Modeling Studies of Novel Compound Mutations Causing Resistance to Multiple Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia.
Iqbal Z; Absar M; Mahmood A; Aleem A; Iqbal M; Jameel A; Akhtar T; Karim S; Rasool M; Mirza Z; Khalid M; Akram AM; Sabar MF; Khalid AM; Aljarrah K; Iqbal J; Khalid M; Shah IH; Alanazi N
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3517-3526. PubMed ID: 33369447
[TBL] [Abstract][Full Text] [Related]
20. Licorice consumption as a cause of posterior reversible encephalopathy syndrome: a case report.
van Beers EJ; Stam J; van den Bergh WM
Crit Care; 2011; 15(1):R64. PubMed ID: 21332974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
